0.00Open0.15Pre Close0 Volume541 Open Interest5.50Strike Price0.00Turnover483.62%IV167.01%PremiumJan 17, 2025Expiry Date0.00Intrinsic Value100Multiplier10DDays to Expiry0.15Extrinsic Value100Contract SizeAmericanOptions Type0.2164Delta0.1723Gamma14.11Leverage Ratio-0.0247Theta0.0001Rho3.05Eff Leverage0.0010Vega
Reviva Pharmaceuticals Stock Discussion
GlobeNewswire· 6 mins ago
Reviva Announces Positive Preliminary Topline Data for the Long-Term Open Label Extension Portion of the Phase 3 RECOVER Study Evaluating Brilaroxazine in Schizophrenia
Monday, 16th December at 8:00 am
– Once daily brilaroxazine demonstrated favorable long-term safety and robust broad-spectrum efficacy sustained over 1-year –
– Generally well-tolerated with low rates of adverse events and discontinuation –
– Full data set from open-label extension (OLE) of R...
$Ascent Solar Technologies (ASTI.US)$- Following delivery and the successful completion of the on-orbi...
📊⚡️📊
📊⚡️📊
📊⚡️📊
No comment yet